Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at ...

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...

The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...

The PMCPA also agreed with the complainant that Pfizer had not taken all possible steps to avoid similar breaches in its ...

The verdict of the US district court in New Jersey is that Shilpa's generic infringes a US patent on multikinase inhibitor ...

In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral carbapenem antibiotic tebipenem HBr for approval before the end of this year after ...

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...

The results show an impressive 63% objective response rate (ORR) in 43 evaluable patients in a phase 2 trial, as of a 27th ...

Drug discovery, and science in general, are fields built on data. Foundation models bring new capabilities by integrating ...

The only available treatment for a patient with coeliac disease is a strict gluten-free diet, which is often not enough on ...

Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections, and, in ...